R3 Vascular Overview
- Year Founded
-
2019

- Status
-
Private
- Employees
-
18

- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$87M
- Investors
-
6
R3 Vascular General Information
Description
Developer and manufacturer of medical device metallic stents designed to treat peripheral arterial diseases. The company offers bioresorbable vascular scaffolds, and BVS technology with a sirolimus coating which has anti-inflammatory properties, enabling physicians to treat peripheral arterial disease below the knee.
Contact Information
Website
www.r3vascular.comCorporate Office
- 1145 Terra Bella Avenue
- Mountain View, CA 94043
- United States
Corporate Office
- 1145 Terra Bella Avenue
- Mountain View, CA 94043
- United States
R3 Vascular Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC (Series B) | 09-May-2024 | $87M | Completed | Generating Revenue | ||
2. Early Stage VC (Series A) | 08-Oct-2020 | Completed | Generating Revenue | |||
1. Seed Round | $800K | $800K | Completed | Stealth |
R3 Vascular Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B1 | ||||||||
Series B | ||||||||
Series A2 | ||||||||
Series A1 | 2,871,593 | $0.000010 | 8% | $0.96 | $0.96 | 1x | $0.96 | 2.31% |
Seed 1 | 6,000,000 | $0.000010 | $0.01 | $0.13 | $0.13 | 1x | $0.13 | 4.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
R3 Vascular Comparisons
Industry
Financing
Details
R3 Vascular Competitors (11)
One of R3 Vascular’s 11 competitors is ShockWave Medical, a Formerly VC-backed company based in Santa Clara, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ShockWave Medical | Formerly VC-backed | Santa Clara, CA | ||||
Vesper Medical | Formerly VC-backed | Wayne, PA | ||||
Inari Medical | Corporation | Irvine, CA | ||||
Endospan | Formerly VC-backed | Herzliya, Israel | ||||
Angiodynamics | Private Debt Financed | Latham, NY |
R3 Vascular Signals
R3 Vascular Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Deerfield Management | Venture Capital | Minority | ||
Philips Ventures | Corporate Venture Capital | Minority | ||
415 Capital | Venture Capital | Minority | ||
MedFocus | Venture Capital | Minority | ||
M&L Healthcare Investments | Venture Capital | Minority |
R3 Vascular FAQs
-
When was R3 Vascular founded?
R3 Vascular was founded in 2019.
-
Where is R3 Vascular headquartered?
R3 Vascular is headquartered in Mountain View, CA.
-
What is the size of R3 Vascular?
R3 Vascular has 18 total employees.
-
What industry is R3 Vascular in?
R3 Vascular’s primary industry is Surgical Devices.
-
Is R3 Vascular a private or public company?
R3 Vascular is a Private company.
-
What is the current valuation of R3 Vascular?
The current valuation of R3 Vascular is
. -
What is R3 Vascular’s current revenue?
The current revenue for R3 Vascular is
. -
How much funding has R3 Vascular raised over time?
R3 Vascular has raised $106M.
-
Who are R3 Vascular’s investors?
Deerfield Management, Philips Ventures, 415 Capital, MedFocus, and M&L Healthcare Investments are 5 of 6 investors who have invested in R3 Vascular.
-
Who are R3 Vascular’s competitors?
ShockWave Medical, Vesper Medical, Inari Medical, Endospan, and Angiodynamics are some of the 11 competitors of R3 Vascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »